Eagle Pharmaceuticals Ownership
| EGRXDelisted Stock | USD 1.99 0.02 1.02% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Eagle |
Eagle Pink Sheet Ownership Analysis
About 12.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.1. Some equities with similar Price to Book (P/B) outperform the market in the long run. Eagle Pharmaceuticals has Price/Earnings To Growth (PEG) ratio of 0.91. The entity had not issued any dividends in recent years. Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey. Eagle Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 102 people.The quote for Eagle Pharmaceuticals is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Eagle Pharmaceuticals call Scott Tarriff at 201 326 5300 or check out https://www.eagleus.com.Eagle Pharmaceuticals Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Eagle Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Eagle Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Eagle Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Brian Cahill over six months ago Disposition of 735 shares by Brian Cahill of Eagle Pharmaceuticals at 5.13 subject to Rule 16b-3 | ||
Scott Tarriff over six months ago Payment of 2119 shares by Scott Tarriff of Eagle Pharmaceuticals subject to Rule 16b-3 | ||
Scott Tarriff over six months ago Disposition of 3154 shares by Scott Tarriff of Eagle Pharmaceuticals at 6.44 subject to Rule 16b-3 | ||
Scott Tarriff over six months ago Sale by Scott Tarriff of 7802 shares of Eagle Pharmaceuticals | ||
Scott Tarriff over a year ago Sale by Scott Tarriff of 10925 shares of Eagle Pharmaceuticals | ||
Scott Tarriff over a year ago Sale by Scott Tarriff of 9511 shares of Eagle Pharmaceuticals | ||
Scott Tarriff over a year ago Payment of 3113 shares by Scott Tarriff of Eagle Pharmaceuticals subject to Rule 16b-3 |
Eagle Pharmaceuticals Outstanding Bonds
Eagle Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Eagle Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Eagle bonds can be classified according to their maturity, which is the date when Eagle Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Eagle Pink Sheet
If you are still planning to invest in Eagle Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eagle Pharmaceuticals' history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |